WEDNESDAY, NOVEMBER 2, 2016
8:00 a.m. – 4:00 p.m. Program
4:00 p.m. – 6:00 p.m. Reception
Life Sciences companies are increasing their engagement with universities in order to collaborate with world-class researchers and supplement their efforts to find novel molecules, treatments, devices and other innovations to enhance or expand their product pipeline.
Join DLA Piper and the University Industry Demonstration Partnership (UIDP) at a workshop designed to provide companies valuable insights on how to structure and manage engagements with universities.
Each session will be led by experienced academic and corporate representatives who will discuss issues critical to university-industry partnerships:
WHO SHOULD ATTEND
- corporate strategy, including the rationale for collaboration, expectations and structures
- operational matters, including intellectual property, contracts, compliance and other administrative issues
- novel issues presented by investigator-initiated clinical trials
- key challenges for life sciences industry companies
Innovation scouts, corporate venture professionals and business development executives from life sciences companies interested in university collaboration and licensing.
Shane Albright, Partner, Corporate, DLA Piper
Rick Friedman, Counsel, Corporate, DLA Piper
Anthony M. Boccanfuso, President, University Industry Demonstration Partnership
Dianne Archer, Corporate Counsel, Gilead Sciences, Inc.
Charles Adelsheim, Research and Strategic Collaborations, Varian Medical Systems
Helene Orescan, JD, Director Clinical Trials Contracts & Strategic Relations, David Geffen School of Medicine at UCLA
Randolph Hall, Vice President of Research, University of Southern California
Elizabeth Adams, Assistant Vice President for Research Administration, University of Virginia
Pramod Khargonekar, Chancellor of University Research, University of
California – Irvine
Anne O'Donnell, Executive Director for Corporate Research Partnerships, UC San Diego
FOR MORE INFORMATION